Food and Drug Administration, U.S. Department of Health and Human Services - December 13, 1988
Brad Stone - (301) 443-3285
The Food and Drug Administration today licensed a five-minute screening test for detecting antibodies to the AIDS virus. This test is the first AIDS-related diagnostic test which uses a protein engineered by recombinant-DNA technology rather than the AIDS virus itself. Useful when a quick screening result is required,
Food and Drug Administration, U.S. Department of Health and Human Services - November 29, 1988
Susan Cruzan - (301) 443-3285
The Food and Drug Administration today approved three tests for the detection of antibodies in blood to a retrovirus called Human T-Lymphotropic Virus Type I, or HTLV-I, which has been linked to a rare leukemia. HTLV-I is a distinct retrovirus associated with a leukemia called Adult T-cell lymphoma wh
Food and Drug Administration, U.S. Department of Health and Human Services - November 21, 1988
Brad Stone (FDA) (301) 443-3285; Elaine Baldwin (NIAID) (301) 496-5717
The Food and Drug Administration today approved the use of alpha interferon to treat Kaposi s Sarcoma -- a systemic cancer which primarily affects AIDS patients. The approval is based in part on a study by scientists at the National Institute of Allergy and Infectious Diseases. (Results of this study will be published
Food and Drug Administration, U.S. Department of Health and Human Services - October 19, 1988
Bill Grigg - (301) 443-3285
The Food and Drug Administration today announced immediate implementation of a plan to reduce the time required for human testing of drugs for life-threatening and severely debilitating diseases. The following is the text of today s statement by FDA Commissioner Frank E. Young, M.D., Ph.D.: Today, we at the Food an
Food and Drug Administration, U.S. Department of Health and Human Services - February 16, 1988
Brad Stone (FDA); (301) 443-3285 Elaine Baldwin (NIAID); (301) 496-5717
The U.S. Public Health Service s Food and Drug Administration and the National Institute of Allergy and Infectious Diseases today announced approval of a treatment IND for the expanded distribution and use of an experimental drug -- trimetrexate -- to treat Pneumocystis carinii pneumonia, a potentially life-threatening
This information is designed to support, not replace, the relationship that exists between you and your doctor.